Limits RegistryPUBLIC RECORD
Limits RegistryThe landmark Stupp chemoradiotherapy protocol reported median overall survival around 14.6 months for newly diagnosed glioblastoma.
The question, scope, and sources behind this Registry record.
The landmark Stupp chemoradiotherapy protocol reported median overall survival around 14.6 months for newly diagnosed glioblastoma.
Track median overall survival reported for a specified newly diagnosed glioblastoma treatment cohort and protocol.
Glioblastoma survival is a cohort-level outcome that depends on age, performance status, molecular subtype, extent of resection, treatment access, and follow-up. The value is therefore a dated treatment-era benchmark, not a patient-specific prognosis.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma — Glioblastoma median overall-survival frontierChange a parameter to stress-test whether a proposed result is still inside the published specification. This is an audit aid, not a proof checker.
Current frontiers derived from accepted Claims.
An observed or demonstrated result; no opposing bound is implied.
The frontier is not sacred
Most progress starts with a disagreement that survives contact with evidence. If you can push the known lower bound up or pull the upper bound down, show us the work.
≥ when you have shown that at least this value is achievable.≤ when you have shown that anything above this value is impossible.No vibes. State the value, define the scope, and link the paper, proof, code, or reproduction that lets another person check it. Editors review every challenge before the public record changes.
Challenge this recordAssertions tied to evidence, attribution, and review.
The frontier as it changed over time.
Only accepted Claims matching the current specification contribute to the displayed bounds. Strict inequalities remain open; contradictory Claims require editorial review.
Permanent ID limitsregistry.com/limits/LR-004219
No active verified bounties are linked to this Limit.
View verified bounty tracker ↗No accepted machine-checked reproductions are recorded for this Limit.
Limits Registry. LR-004219. Glioblastoma median overall-survival frontier. 2026.